IRVINE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced today that Michael R. Rodriguez, Senior Vice President Finance and Chief Financial Officer, is scheduled to make an investor presentation at the 2006 Southern California Investor Conference at 9:00 a.m. PT (12 noon ET) on Friday, August 11, 2006. The conference is being held at the Hyatt Regency in Irvine, CA.
A live webcast of the Company’s presentation will be available via a link provided on the Company’s website at www.endocare.com/investors/webcasts.php. Web participants are encouraged to go to the Company’s website at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.
About Endocare
Endocare, Inc. (www.endocare.com) is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver.
Investor Contact: Media Contact: For Additional Information: Matt Clawson Len Hall Craig T. Davenport, CEO Allen & Caron, Inc. Allen & Caron, Inc. Michael R. Rodriguez, CFO (949) 474-4300 (949) 474-4300 Endocare, Inc. matt@allencaron.comlen@allencaron.com (949) 450-5400 www.allencaron.comwww.allencaron.comwww.endocare.com
Endocare, Inc.
CONTACT: Craig T. Davenport, CEO, or Michael R. Rodriguez, CFO, both ofEndocare, Inc., +1-949-450-5400; or Investors, Matt Clawson,matt@allencaron.com, or Media, Len Hall, len@allencaron.com, both of Allen& Caron, Inc., +1-949-474-4300, for Endocare, Inc.
